La Roche-Posay
La Roche-Posay Cicaplast Baume B5+
Low risk79/100
La Roche-Posay
Cicaplast B5 Facial Sheet Mask
Sheet Masks
No higher-risk flags in the assessed ingredients. This is a screening result, not a guarantee of pregnancy safety.
15 of 15 ingredients rated
Is it suitable during pregnancy?
MamaSkin rates the recorded formula for La Roche-Posay Cicaplast B5 Facial Sheet Mask as No known risks (99/100). This screening result is not a guarantee of safety for every pregnancy.
Why this rating?
No higher-risk ingredient flags are shown in the assessed entries. Ingredients without a matched rating are marked Not assessed, not No known risks.
15 of 15 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.
How we assess productsIngredient breakdown
The recorded formula, with evidence behind each rating. Unmatched ingredients are marked Not assessed in grey.
Ingredient ratings and evidence
Higher-risk flags first. Open an ingredient for evidence.
Water
No known risks
Water (Aqua) is the standard purified water used as a cosmetic solvent. It has no pregnancy-specific risk in normal topical use.
Sources: https://pubchem.ncbi.nlm.nih.gov/compound/Water, https://single-market-economy.ec.europa.eu/sectors/cosmetics/cosmetic-ingredient-database/cosing-glossary-ingredients_en
Glycerin
No known risks
Glycerin is a widely used humectant that supports hydration and the skin barrier, with a long safety record and no known pregnancy or breastfeeding concerns in topical cosmetic use.
Sources: CIR; EU/UK Cosmetics Regulation
Propanediol
No known risks
Solvent and humectant used to improve texture and ingredient solubility. Low systemic exposure expected from topical cosmetic use.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Butylene Glycol
No known risks
Solvent and humectant commonly used in leave-on products. Not associated with pregnancy-specific concerns at cosmetic exposure levels.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Propylene Glycol
No known risks
Propylene glycol is a common solvent and humectant with a long history of use; it is not considered a pregnancy or breastfeeding concern in topical cosmetics, though some individuals may experience irritation in leave-on products.
Sources: CIR; EU/UK Cosmetics Regulation
Show all 15 ingredients
Pentylene Glycol
No known risks
Humectant and preservative booster. Considered safe for cosmetic use with low systemic exposure.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
PEG/PPG/Polybutylene Glycol-8/5/3 Glycerin
No known risks
peg/ppg/polybutylene glycol-8/5/3 glycerin is a high-molecular-weight cosmetic polymer or film former. Dermal absorption is expected to be limited when manufactured with appropriate residual-monomer and impurity controls. Relevant CIR polymer assessments did not identify a pregnancy-specific concern for normal topical use; airborne powder or spray droplets should not be inhaled.
Sources: CIR Amended Safety Assessment of Acrylates Copolymers https://cir-safety.org/ingredient/acrylates-copolymer; CIR vinylpyrrolidone-polymer assessment.
Madecassoside
No known risks
A triterpene glycoside associated with Centella asiatica and used in soothing and skin-conditioning formulas. Pregnancy-specific evidence for isolated topical madecassoside is limited. Cosmetic safety reviewers considered Centella-derived ingredients acceptable at current cosmetic exposure but noted that madecassoside and related triterpenes may contribute to sensitisation, so products should be formulated to avoid sensitising concentrations. No pregnancy-specific topical contraindication was identified in the reviewed material.
Sources: CIR: Safety Assessment of Centella asiatica-Derived Ingredients as Used in Cosmetics https://cir-safety.org/supplementaldoc/safety-assessment-centella-asiatica-derived-ingredients-used-cosmetics-1
Sodium Hyaluronate
No known risks
Sodium hyaluronate (hyaluronic acid salt) is used for hydration and cushioning, with very low systemic absorption from topical use and no known pregnancy or breastfeeding concerns at cosmetic concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
Sodium Polyacrylate
No known risks
Polymer used for texture and absorbency. Large-molecule ingredient with low systemic exposure.
Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)
Ammonium Polyacryloyldimethyl Taurate
No known risks
A high-molecular-weight polymer used to thicken and stabilise formulas. Cosmetic safety reviewers concluded that acryloyldimethyltaurate polymers are safe in current cosmetic practices. Absorption of the finished polymer is expected to be limited, with residual monomers controlled during manufacture.
Sources: CIR: Safety Assessment of Acryloyldimethyltaurate Polymers as Used in Cosmetics; final report April 2017 https://cir-safety.org/sites/default/files/QRT-Update-Dec2025.pdf
Disodium EDTA
No known risks
Disodium EDTA is a chelating agent used to improve formula stability and performance; it is considered low concern in topical cosmetic use, with no known pregnancy or breastfeeding risks at typical concentrations.
Sources: CIR; EU/UK Cosmetics Regulation
Citric Acid
No known risks
pH adjuster used in small amounts to maintain product stability. Not associated with pregnancy-specific concerns.
Sources: Scientific Committee on Consumer Safety (EU); European cosmetics regulatory framework
Xanthan Gum
No known risks
Natural polysaccharide thickener used for stability and texture. Not associated with pregnancy-specific concerns.
Sources: European cosmetics regulatory framework
Panthenol
No known risks
Panthenol (pro-vitamin B5) is used for soothing and barrier support and is generally well tolerated, with no known pregnancy or breastfeeding concerns in topical cosmetic use.
Sources: CIR; EU/UK Cosmetics Regulation
Full recorded ingredient list
Water, Glycerin, Propanediol, Butylene Glycol, Propylene Glycol, Pentylene Glycol, PEG/PPG/Polybutylene Glycol-8/5/3 Glycerin, Madecassoside, Sodium Hyaluronate, Sodium Polyacrylate, Ammonium Polyacryloyldimethyl Taurate, Disodium EDTA, Citric Acid, Xanthan Gum, Panthenol
Ingredient ratings refreshed 1 October 2026. Formulas vary by market and can change. Always compare with your packaging.
Questions about this assessment
Why does La Roche-Posay Cicaplast B5 Facial Sheet Mask have a No known risks rating?
No higher-risk ingredient flags are shown in the assessed entries. Ingredients without a matched rating are marked Not assessed, not No known risks. The product score is a stored assessment, not a clinical safety guarantee.
Does a barrier-care product name establish pregnancy suitability?
No. This recorded formula contains Panthenol or Madecassoside, but a barrier-care claim does not establish the assessment of all its other ingredients. Read the individual ingredient evidence and any manual-review explanation, and compare the recorded list with your packaging.
Has every ingredient in La Roche-Posay Cicaplast B5 Facial Sheet Mask been assessed?
15 of 15 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.
Does this assessment apply to my La Roche-Posay Cicaplast B5 Facial Sheet Mask?
Only if the ingredient list on your packaging matches the recorded formula shown here. Formulas can differ by market and change over time. Compare the full list, not just the product name; report a mismatch if it differs.
Does this pregnancy assessment also establish breastfeeding suitability?
No. This page presents a pregnancy-focused product assessment. Do not infer a breastfeeding conclusion from its score or label; breastfeeding requires a separate assessment of the formula and how it is used.
